VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164(b) therapy

BACKGROUND: Ulcerative colitis (UC) is the most common form of inflammatory bowel disease in the USA. A key component of UC is the increase in inflammatory angiogenesis of the colon during active disease. This increase is driven to a great extent by the over expression of VEGF-A. Recently, VEGF165(b...

Descripción completa

Detalles Bibliográficos
Autores principales: Cromer, Walter E, Ganta, Chaitanya V, Patel, Mihir, Traylor, James, Kevil, Christopher G, Alexander, J Steven, Mathis, J Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848761/
https://www.ncbi.nlm.nih.gov/pubmed/24020796
http://dx.doi.org/10.1186/1479-5876-11-207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848761/
https://www.ncbi.nlm.nih.gov/pubmed/24020796
http://dx.doi.org/10.1186/1479-5876-11-207

Ejemplares similares